The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Grifols SA ADR (GRFS) shows that investor sentiment remained same, with the stock’s consolidated last price to $9.31. The Grifols SA ADR has recorded 69,816 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Araclon Biotech Presents Positive Final Results from Phase 2 Clinical Study of ABvac40 Alzheimer’s Vaccine at CTAD.
Grifols SA ADR is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Drug Manufacturers – General industry. At the end of the last regular session, the stock closed at $9.31 and fluctuated between $9.47 as its day high and $9.12 as its day low. The current market capitalization of Grifols SA ADR is $2.39B. A total of 0.97 million shares were traded on the day, compared to an average of 500.98K shares.
It is more appealing for investors to invest in companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook for the company. Grifols SA ADR pays an annual dividend of $0.01, resulting in a dividend yield of 0.16%, and it has a price to earnings (P/E) ratio of 1330.00. GRFS’s most recent ex-dividend date was 6/3/2021 when it declared a $0.4385 quarterly dividend that was paid in cash on 6/14/2021. Previously, the company paid the dividend on 11/9/2020 with an ex-dividend date of 10/30/2020. The GRFS stock dividend was $0.1445 per share in cash.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for GRFS in the last 3 months, the mean price target is $15.71 with high estimates of $19.50 and low estimates of $10.00. In terms of 52-week highs and lows, GRFS has a high of $10.97 and a low of $6.35.
As of this writing, GRFS has an earnings estimate of $0.24 per share for the current quarter. EPS was calculated based on a consensus of 2 estimates, with a high estimate of $0.33 per share and a lower estimate of $0.14. The company reported an EPS of $0.04 in the last quarter, which was -81.00% lower than expectations of $0.21.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. GRFS’s latest balance sheet shows that the firm has $2.68B in Cash & Short Term Investments as of fiscal 2021. There were $9.32B in debt and $3.47B in liabilities at the time. Its Book Value Per Share was $9.42, while its Total Shareholder’s Equity was $8.15B.
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GRFS is Buy with a score of 4.33.